[{"id":"b409f22b-fefb-4eb1-b62a-798f13e361a5","acronym":"","url":"https://clinicaltrials.gov/study/NCT02453464","created_at":"2021-01-18T11:46:03.918Z","updated_at":"2024-07-02T16:37:32.641Z","phase":"Phase 1","brief_title":"A Phase Ib Study of Humanized Anti-VEGF Monoclonal Antibody (Sevacizumab) Injection Plus FOLFIRI in Chinese Patients With Metastatic Colorectal Cancer","source_id_and_acronym":"NCT02453464","lead_sponsor":"Jiangsu Simcere Pharmaceutical Co., Ltd.","biomarkers":" VEGFA","pipe":"","alterations":" ","tags":["VEGFA"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e 5-fluorouracil • irinotecan • leucovorin calcium • Enzeshu (suvemcitug)"],"overall_status":"Unknown status","enrollment":" Enrollment 36","initiation":"Initiation: 08/01/2015","start_date":" 08/01/2015","primary_txt":" Primary completion: 12/01/2016","primary_completion_date":" 12/01/2016","study_txt":"","study_completion_date":"","last_update_posted":"2016-04-20"}]